Your cat was diagnosed with GI Lymphoma, Small Cell (Low Grade). Most common form of feline lymphoma. Alimentary lymphoma is the most common anatomical form in cats. UK incidence ~32/100,000 cats. Compare 3 treatment options for cats including Chlorambucil + Prednisolone, Cyclophosphamide Rescue (Relapsed Small Cell), Prednisolone Alone — with survival times, costs, and what to expect during treatment.
Pet Cancer Options — GI Lymphoma, Small Cell (Low Grade)
Feline Oncology Treatment Guide
GI Lymphoma, Small Cell (Low Grade)
GI-localised
Round Cell
About This Cancer
Small cell (low-grade) gastrointestinal lymphoma is the most common cancer in cats and the most common form of feline lymphoma. It arises from lymphocytes — most often T-cells — that normally reside in the lining of the intestinal wall. These malignant lymphocytes accumulate gradually, disrupting the intestine's ability to absorb nutrients properly. Affected cats typically show chronic, slowly progressive signs such as weight loss, intermittent vomiting, decreased appetite, or diarrhoea. Because these symptoms closely mimic inflammatory bowel disease (IBD), and because distinguishing the two conditions can require full-thickness intestinal biopsies, diagnosis can be challenging. The good news is that small cell GI lymphoma generally responds well to oral chemotherapy (chlorambucil and prednisolone), with many cats achieving remission for one to three years or longer and maintaining an excellent quality of life throughout treatment.
WHO Modified Staging for Feline Lymphoma
Anatomical staging system adapted for cats. GI lymphoma is typically classified by histological grade (small cell vs large cell) rather than WHO stage, as most present as diffuse GI infiltration.
Prognostic Factors(4)
Minimum Workup(8 steps)
Median Survival Time Comparison
How long the average patient survives with each treatment
Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.
Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.